The nonclinical stage refers to the evaluation of the potential use of drug candidates for humans by conducting in vitro and in vivo animal studies under laboratory conditions, aiming to observe the biological activities of the drug candidates against the target diseases. This stage mainly includes bioanalytical, pharmacology/pharmacodynamic, pharmacokinetic and toxicology studies.

InnoStar's nonclinical assessment sector covers nonclinical pharmacodynamic, nonclinical pharmacokinetic and nonclinical safety evaluation services. According to customers' projects, oriented by customers’ demands, through the matrix management mode, with the projects/tasks as the center to build the PL+PM project execution team, appropriate study protocols are designed and implemented to meet customers’ needs in scientific nature, quality, efficiency and other dimensions.

Platform advantages

InnoStar has built an interdisciplinary, multi-level, and highly-educated expert team, and its core technical team consists of a group of senior scientists with rich guidance experience and international vision in the industry. InnoStar's expert team always adheres to the scientific and innovative concepts and continuously strengthens and consolidates its own technological advantages, to provide highly customized services in new drug research and development for customers, and to meet pharmaceutical companies' individualized, diversified, innovative, and international one-stop demand of new drug nonclinical assessment.